Ignite Creation Date:
2025-12-24 @ 4:21 PM
Ignite Modification Date:
2026-01-10 @ 6:08 PM
Study NCT ID:
NCT00652366
Status:
COMPLETED
Last Update Posted:
2015-02-11
First Post:
2008-04-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-05
Start Date Type:
None
Primary Completion Date:
2012-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-02
Completion Date Type:
ACTUAL
First Submit Date:
2008-04-01
First Submit QC Date:
None
Study First Post Date:
2008-04-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-12-08
Results First Submit QC Date:
None
Results First Post Date:
2015-02-11
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-01-27
Last Update Post Date:
2015-02-11
Last Update Post Date Type:
ESTIMATED